Selumetinib Plus Docetaxel Compared With Docetaxel Alone...

JAMA The Journal of the American Medical Association 2017 / 05 Vol. 317; Iss. 18

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS -Mutant Advanced Non–Small Cell Lung Cancer

Jänne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
317
Language:
english
Journal:
JAMA
DOI:
10.1001/jama.2017.3438
Date:
May, 2017
File:
PDF, 479 KB
english, 2017
Conversion to is in progress
Conversion to is failed